Robot and Mirror Therapy Compared for Stroke Arm Recovery
Tests robotic therapy with mirror therapy against usual rehabilitation in people with stroke.
Plain-language title generated from the registry record
Registry title: Robotic Therapy Hybridized With Mirror Therapy in Stroke Rehabilitation
Key facts
- Where
- Taipei and Taipei, Taiwan, TaiwanSee the 2 sites
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who had a first stroke 3 months to 2 years ago and have some arm weakness. It compares robotic plus mirror therapy with usual rehabilitation.
- Age
- 30 to 80 years
- Sex
- All sexes can join.
- Disease stage
- First-ever stroke, at least 3 months and less than 2 years ago. Upper arm and hand movement score (FMA-UE) between 18 and 56. No excessive muscle stiffness (Modified Ashworth Scale below 3 at any joint).
- Earlier treatment
- No botulinum toxin injections in the past 3 months. No other experimental rehabilitation or drug study during this trial.
- Biomarker or test result
- Thinking test (Montreal Cognitive Assessment) score of 22 or more, so the person can follow instructions.
Main reasons for not taking part
- Acute inflammation and pain
- Botulinum toxin injection in the past 3 months
- Broken bone in an arm or hand in the past 3 months
- Other nerve, muscle or bone conditions that could interfere with taking part
- Taking part in another experimental rehabilitation or drug study
Read by machine on 12 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 30 and 80 years old?
Source: NCT06777654, who can take part
Where in Taiwan
- Wan Fang Hospital, Taipei Medical UniversityTaipei, TaiwanNo longer taking part
- National Taiwan University HospitalTaipei, Taiwan, TaiwanNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- National Taiwan University Hospital
- Trial code
- NCT06777654
- Record updated
- 27 March 2025
- Original description
The goal of this clinical trial is to compare the effects of three groups: (1) unilateral robotic therapy with computerized visual feedback plus unilateral innovative mirror therapy, (2) bilateral robotic therapy with computerized visual feedback plus bilateral innovative mirror therapy, and (3) dose-matched conventional rehabilitation as the control. The investigators will also study the factors predictive of treatment success, identify key predictors of clinical improvement, and distinguish patient profiles most likely to benefit from each regimen. The findings of this clinical trial are expected to advance knowledge about the synergistic effects of unilateral and bilateral hybrid programs. The predictive study of treatment outcomes will inform patient selection in precision rehabilitation toward personalized stroke management.Read full original descriptionShow less
Unilateral and Bilateral Approaches to Robotic Therapy Hybridized With Mirror Therapy in Stroke Rehabilitation
The goal of this clinical trial is to compare the effects of three groups: (1) unilateral robotic therapy with computerized visual feedback plus unilateral innovative mirror therapy, (2) bilateral robotic therapy with computerized visual feedback plus bilateral innovative mirror therapy, and (3) dose-matched conventional rehabilitation as the control. The investigators will also study the factors predictive of treatment success, identify key predictors of clinical improvement, and distinguish patient profiles most likely to benefit from each regimen. The findings of this clinical trial are expected to advance knowledge about the synergistic effects of unilateral and bilateral hybrid programs. The predictive study of treatment outcomes will inform patient selection in precision rehabilitation toward personalized stroke management.
Inclusion: (1) a first ever-stroke≧3 months and less than 2 years, (2) age range between 30 to 80 years, (3) baseline Fugl-Meyer Assessment-Upper Extremity subscale (FMA-UE) between 18 to 56, (4) no excessive muscle spasticity of the affected extremities (Modified Ashworth Scale < 3 at any joints), (5) able to follow examiners' commands and study instructions (Montreal Cognitive Assessment score≧22), and (6) no fracture of upper extremities within the past 3 months, and (7) no participation in any other experimental rehabilitation or drug studies during study period of this project.
Exclusion: (1) acute inflammation and pain, (2) receiving botulinum toxin injections within the past 3 months, and (3) concomitant neurologic, neuromuscular or orthopedic conditions that may interfere with participation in this research.